1. Canakinumab in adults with steroid‐refractory pyoderma gangrenosum. (16th October 2015) Authors: Kolios, A.G.A.; Maul, J.‐T.; Meier, B.; Kerl, K.; Traidl‐Hoffmann, C.; Hertl, M.; Zillikens, D.; Röcken, M.; Ring, J.; Facchiano, A.; Mondino, C.; Yawalkar, N.; Contassot, E.; Navarini, A.A.; French, L.E. Journal: British journal of dermatology Issue: Volume 173:Number 5(2015:Nov.) Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Canakinumab in adults with steroid‐refractory pyoderma gangrenosum. (1st November 2015) Authors: Kolios, A.G.A.; Maul, J.‐T.; Meier, B.; Kerl, K.; Traidl‐Hoffmann, C.; Hertl, M.; Zillikens, D.; Röcken, M.; Ring, J.; Facchiano, A.; Mondino, C.; Yawalkar, N.; Contassot, E.; Navarini, A.A.; French, L.E. Journal: British journal of dermatology Issue: Volume 173:Number 5(2015:Nov.) Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical factors for predicting clinical responses to methotrexate. (1st October 2019) Authors: Yan, K.X.; Zhang, Y.J.; Han, L.; Huang, Q.; Zhang, Z.H.; Fang, X.; Zheng, Z.Z.; Yawalkar, N.; Chang, Y.L.; Zhang, Q.; Jin, L.; Qian, D.F.; Li, X.Y.; Wu, M.S.; Xu, Q.H.; Zhang, X.J.; Xu, J.H. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: e97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations. (21st December 2020) Authors: Nast, A.; Smith, C.; Spuls, P.I.; Avila Valle, G.; Bata‐Csörgö, Z.; Boonen, H.; De Jong, E.; Garcia‐Doval, I.; Gisondi, P.; Kaur‐Knudsen, D.; Mahil, S.; Mälkönen, T.; Maul, J.T.; Mburu, S.; Mrowietz, U.; Reich, K.; Remenyik, E.; Rønholt, K.M.; Sator, P.G.; Schmitt‐Egenolf, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 11(2020) Page Start: 2461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations. (5th February 2021) Authors: Nast, A.; Smith, C.; Spuls, P.I.; Avila Valle, G.; Bata‐Csörgö, Z.; Boonen, H.; De Jong, E.; Garcia‐Doval, I.; Gisondi, P.; Kaur‐Knudsen, D.; Mahil, S.; Mälkönen, T.; Maul, J.T.; Mburu, S.; Mrowietz, U.; Reich, K.; Remenyik, E.; Rønholt, K.M.; Sator, P.G.; Schmitt‐Egenolf, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC. (19th October 2015) Authors: Nast, A.; Gisondi, P.; Ormerod, A.D.; Saiag, P.; Smith, C.; Spuls, P.I.; Arenberger, P.; Bachelez, H.; Barker, J.; Dauden, E.; de Jong, E.M.; Feist, E.; Jacobs, A.; Jobling, R.; Kemény, L.; Maccarone, M.; Mrowietz, U.; Papp, K.A.; Paul, C.; Reich, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 12(2015:Dec.) Page Start: 2277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gender and age significantly determine patient needs and treatment goals in psoriasis – a lesson for practice. (15th January 2019) Authors: Maul, J.‐T.; Navarini, A.A.; Sommer, R.; Anzengruber, F.; Sorbe, C.; Mrowietz, U.; Drach, M.; Blome, C.; Boehncke, W.‐H.; Thaci, D.; Reich, K.; von Kiedrowski, R.; Körber, A.; Yawalkar, N.; Mainetti, C.; Laffitte, E.; Streit, M.; Rustenbach, S.; Conrad, C.; Borradori, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IgE and FcεRI are highly expressed on innate cells in psoriasis. (18th April 2016) Authors: Yan, K‐X.; Huang, Q.; Fang, X.; Zhang, Z‐H.; Han, L.; Gadaldi, K.; Kang, K‐F.; Zheng, Z‐Z.; Xu, J‐H.; Yawalkar, N. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IgE and FcεRI are highly expressed on innate cells in psoriasis. (1st July 2016) Authors: Yan, K‐X.; Huang, Q.; Fang, X.; Zhang, Z‐H.; Han, L.; Gadaldi, K.; Kang, K‐F.; Zheng, Z‐Z.; Xu, J‐H.; Yawalkar, N. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IgE and FcεRI are highly expressed on innate cells in psoriasis3. (18th April 2016) Authors: Yan, K‐X.; Huang, Q.; Fang, X.; Zhang, Z‐H.; Han, L.; Gadaldi, K.; Kang, K‐F.; Zheng, Z‐Z.; Xu, J‐H.; Yawalkar, N. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗